@article{article7ee8436b,
title   = {Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates},
author = {Fonseca, Ana Rita da and Justino, Caio Cesar and Molla, Vinicius Campos de and Yamakawa, Patricia Eiko and Rabelo, Iara Baldim and Arnold, Louise and Kelly, Richard and Grif, Morag and Munir, Talha and Velloso, Elvira Deolinda Rodrigues Pereira},
year = {2025},
doi = {10.1182/bloodadvances.2024014159},
journal   = {Blood advances}
}